rs151344454
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_000397.4(CYBB):c.1609T>C(p.Cys537Arg) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000397.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYBB | NM_000397.4 | c.1609T>C | p.Cys537Arg | missense_variant | Exon 13 of 13 | ENST00000378588.5 | NP_000388.2 | |
CYBB | XM_047441855.1 | c.1303T>C | p.Cys435Arg | missense_variant | Exon 12 of 12 | XP_047297811.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYBB | ENST00000378588.5 | c.1609T>C | p.Cys537Arg | missense_variant | Exon 13 of 13 | 1 | NM_000397.4 | ENSP00000367851.4 | ||
ENSG00000250349 | ENST00000465127.1 | c.171+384813T>C | intron_variant | Intron 3 of 8 | 5 | ENSP00000417050.1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Granulomatous disease, chronic, X-linked Pathogenic:2
This variant has been observed in several individuals affected with X-linked chronic granulomatous disease (PMID: 22540226, 28168067, 12589359, 9585602). This variant is also referred to as c.1621T>C in the literature. ClinVar contains an entry for this variant (Variation ID: 68386). This variant is not present in population databases (ExAC no frequency). This sequence change replaces cysteine with arginine at codon 537 of the CYBB protein (p.Cys537Arg). The cysteine residue is highly conserved and there is a large physicochemical difference between cysteine and arginine. This variant has been reported to affect CYBB protein function (PMID: 20724480). For these reasons, this variant has been classified as Pathogenic. -
Variant summary: The CYBB c.1609T>C (p.Cys537Arg) variant located in the NADPH binding domain involves the alteration of a conserved nucleotide and 5/5 in silico tools predict a damaging outcome. Multiple functional studies, Jirapongsananuruk_2003, de Oliveria-Junior_2012, and Desbeurme_2010 indicate that the variant has a pathogenic effect on the protein, imparticular causing no detectable NADPH oxidase activity. The variant of interest was not observed in 86762 control chromosomes (ExAC) and multiple publications have cited the variant in affected individuals. Furthermore, multiple clinical diagnostic laboratories/reputable databases classified this variant as pathogenic. Taken together, this variant is classified as pathogenic. -
not provided Pathogenic:1Other:1
Published functional studies demonstrate the variant nearly abolishes NADPH oxidase activity and leads to steric conflicts likely incompatible with NADPH orientation (Debeurme et al., 2010); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 21190454, 12139950, 12589359, 26210446, 9585602, 20729109, 29560547, 34175765, 31172472, 35796921, 28168067, 22540226, 30506560, 20724480) -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at